Literature DB >> 27913281

Beyond emotion recognition deficits: A theory guided analysis of emotion processing in Huntington's disease.

Catarina C Kordsachia1, Izelle Labuschagne2, Julie C Stout3.   

Abstract

Deficits in facial emotion recognition in Huntington's disease (HD) have been extensively researched, however, a theory-based integration of these deficits into the broader picture of emotion processing is lacking. To describe the full extent of emotion processing deficits we reviewed the clinical research literature in HD, including a consideration of research in Parkinson's disease, guided by a theoretical model on emotion processing, the Component Process Model. Further, to contribute to understanding the mechanisms underlying deficient emotion recognition, we discussed the literature in light of specific emotion recognition theories. Current evidence from HD studies indicates deficits in the production of emotional facial expressions and alterations in subjective emotional experiences, in addition to emotion recognition deficits. Conceptual understanding of emotions remains relatively intact. Impaired recognition and expression of emotion in HD might be linked, whereas altered emotional experiences appear to be unrelated to emotion recognition. A key implication of this review is the need to take all the components of emotion processing into account to understand specific deficits in neurodegenerative diseases.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Component process model; Emotion processing; Emotion recognition; Huntington’s disease

Mesh:

Year:  2016        PMID: 27913281     DOI: 10.1016/j.neubiorev.2016.11.020

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  8 in total

1.  Social Cognition and Oxytocin in Huntington's Disease: New Insights.

Authors:  Elisa Unti; Sonia Mazzucchi; Daniela Frosini; Cristina Pagni; Gloria Tognoni; Lionella Palego; Laura Betti; Fabiana Miraglia; Gino Giannaccini; Roberto Ceravolo
Journal:  Brain Sci       Date:  2018-08-26

2.  Apathy Associated With Impaired Recognition of Happy Facial Expressions in Huntington's Disease.

Authors:  Katherine Osborne-Crowley; Sophie C Andrews; Izelle Labuschagne; Akshay Nair; Rachael Scahill; David Craufurd; Sarah J Tabrizi; Julie C Stout
Journal:  J Int Neuropsychol Soc       Date:  2019-02-15       Impact factor: 2.892

3.  Abnormal Visual Scanning of Emotionally Evocative Natural Scenes in Huntington's Disease.

Authors:  Catarina C Kordsachia; Izelle Labuschagne; Julie C Stout
Journal:  Front Psychol       Date:  2017-03-29

4.  Visual Object Perception in Premanifest and Early Manifest Huntington's Disease.

Authors:  Emma M Coppen; Milou Jacobs; Kasper F van der Zwaan; Huub A M Middelkoop; Raymund A C Roos
Journal:  Arch Clin Neuropsychol       Date:  2019-11-27       Impact factor: 2.813

5.  Emotion recognition and inhibitory control in manifest and pre-manifest Huntington's disease: evidence from a new Stroop task.

Authors:  Thomas Hunefeldt; Sabrina Maffi; Simone Migliore; Ferdinando Squitieri; Marta Olivetti Belardinelli
Journal:  Neural Regen Res       Date:  2020-08       Impact factor: 5.135

6.  The level of cognitive function and recognition of emotions in older adults.

Authors:  Marianna Virtanen; Archana Singh-Manoux; G David Batty; Klaus P Ebmeier; Markus Jokela; Catherine J Harmer; Mika Kivimäki
Journal:  PLoS One       Date:  2017-10-04       Impact factor: 3.240

7.  The Alteration of Emotion Regulation Precedes the Deficits in Interval Timing in the BACHD Rat Model for Huntington Disease.

Authors:  Daniel Garces; Nicole El Massioui; Charlotte Lamirault; Olaf Riess; Huu P Nguyen; Bruce L Brown; Valérie Doyère
Journal:  Front Integr Neurosci       Date:  2018-05-09

8.  Structural and functional changes of the visual cortex in early Huntington's disease.

Authors:  Emma M Coppen; Jeroen van der Grond; Anne Hafkemeijer; Jurriaan J H Barkey Wolf; Raymund A C Roos
Journal:  Hum Brain Mapp       Date:  2018-08-24       Impact factor: 5.038

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.